Capital Market Strategies’s iShares Biotechnology ETF IBB Stock Holding History

Capital Market Strategies’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$320K	Sell	2,529 -195	-7%	-$23.9K	0.22%	93
2025 Q1	$348K	Hold	2,724	–	–	0.23%	87
2024 Q4	$360K	Sell	2,724 -3	-0.1%	-$422	0.21%	103
2024 Q3	$397K	Hold	2,727	–	–	0.24%	84
2024 Q2	$374K	Buy	2,727 +450	+20%	+$60.1K	0.24%	85
2024 Q1	$312K	Sell	2,277 -112	-5%	-$15.3K	0.24%	95
2023 Q4	$325K	Sell	2,389 -150	-6%	-$18.3K	0.28%	85
2023 Q3	$303K	Sell	2,539 -100	-4%	-$12.7K	0.3%	83
2023 Q2	$335K	Buy	+2,639	New	+$343K	0.31%	82
2023 Q1	–	Sell	-2,618	Closed	-$344K	–	79
2022 Q4	$344K	Sell	2,618 -2	-0.1%	-$258	0.37%	74
2022 Q3	$306K	Sell	2,620 -50	-2%	-$6.21K	0.34%	85
2022 Q2	$314K	Hold	2,670	–	–	0.33%	88
2022 Q1	$348K	Sell	2,670 -374	-12%	-$48.7K	0.3%	91
2021 Q4	$465K	Buy	+3,044	New	+$471K	0.38%	70

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Capital Market Strategies's IBB Position: Q2 2025 in Review

Capital Market Strategies reduced its iShares Biotechnology ETF (IBB) stake by 7.2% in Q2 2025, selling an estimated $23.9K and leaving 2,529 shares worth $320K. The position accounts for 0.22% of the portfolio, ranked #93.

Capital Market Strategies first reported a position in IBB in Q4 2021 and has held it in 14 quarters since. The position peaked at $465K in Q4 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

Capital Market Strategies held 2,529 shares of iShares Biotechnology ETF worth $320K as of Q2 2025.
Capital Market Strategies sold 195 iShares Biotechnology ETF shares in Q2 2025, an estimated $23.9K.
iShares Biotechnology ETF made up 0.22% of Capital Market Strategies's portfolio in Q2 2025, its #93 holding.
Capital Market Strategies first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 14 quarters since.
Capital Market Strategies's iShares Biotechnology ETF position peaked at $465K in Q4 2021.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Capital Market Strategies's 13F filing for Q2 2025, filed 2 Jul 2025.